Maternal lupus and the fetal heart: the structural risk is the clearer one

Design

Systematic review and random-effects meta-analysis with Freeman-Tukey transformation, meta-regression and prespecified subgroups

Population

33,694 lupus-associated pregnancies across 53 studies, searched to January 2026

Primary outcome

Pooled incidence of structural cardiovascular malformations and congenital heart block in offspring

Effect

Structural malformations 3.29% (95% CI 2.48-4.21%), OR versus controls 3.52 (2.13-5.81) unadjusted and 1.70 (1.22-2.36) adjusted; congenital heart block 1.29% (0.82-1.88%)

Counselling a woman with lupus about pregnancy usually leads with congenital heart block, because it is the outcome everyone has heard of. This meta-analysis of 53 studies and 33,694 lupus-associated pregnancies suggests the emphasis may be the wrong way round.

Pooled incidence was 3.29% (95% CI 2.48-4.21%) for structural cardiovascular malformations across 41 studies and 32,133 pregnancies, and 1.29% (95% CI 0.82-1.88%) for congenital heart block across 45 studies and 28,117 pregnancies. Compared with healthy controls, offspring of mothers with lupus had a raised risk of structural malformations (OR 3.52, 95% CI 2.13-5.81), which persisted in a pooled analysis of five multivariable-adjusted studies (OR 1.70, 95% CI 1.22-2.36, P=0.002). For heart block the comparative estimate was elevated but, in the authors' words, highly imprecise and statistically unstable.

Two correlates emerged. Active disease was associated with structural malformations in study-level meta-regression (P=0.024). And heart block prevalence was far higher in studies where cases occurred in anti-SSA/Ro-positive mothers (2.64%) than in studies not reporting antibody status (0.63%, P for interaction <0.001) — which is consistent with everything known about the mechanism, and is the variable that should drive surveillance.

The drop from an unadjusted OR of 3.52 to an adjusted 1.70 is the part to carry into a counselling conversation. Much of the apparent excess is explained by things other than the lupus diagnosis itself, and the authors are explicit that adjustment remained incomplete.

• Anti-SSA/Ro status, not the lupus diagnosis, is what should drive fetal heart surveillance
• Disease activity at conception is the modifiable correlate — that is the pre-pregnancy conversation
• Quote the adjusted OR of 1.70, not the unadjusted 3.52, when counselling
• Structural malformation at 3.29% is the commoner outcome; heart block at 1.29% is the feared one
• Medication exposure was not adequately adjusted for across studies, and that matters here

Why it matters

The risk most prominent in counselling is the less well-established of the two, and the better-established one is partly explained by other factors.

Don't overread it

Pooled observational data with incomplete adjustment for antibody status, disease activity, medication and surveillance intensity — the independent contribution of lupus itself is uncertain.

The statistics, in plain English

The gap between the crude odds ratio (3.52) and the adjusted one (1.70) is the story: roughly half the apparent excess risk disappears once you account for other factors, and the adjustment was incomplete, so more may yet. 'Statistically unstable' for the heart block estimate means the events were rare enough that the pooled figure moved substantially with small changes in method — a warning not to quote it. The subgroup difference by antibody status is the most mechanistically sound finding here.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.